ATR and gastric cancer: In gastric cancer, 37 compounds were examined by constructing a library of patient-derived gastric cancer organoid biospecimens, Some new potent compounds such as Abemaciclib, Napabucasin and ATR inhibitor VE-822 had been identified and showed antitumor effects in clinical trials (Yan et al., 2018).